Dare Bioscience, Inc. — Director's Dealing 2021

Apr 20, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Dare Bioscience, Inc. (DARE)
CIK: 0001401914
Period of Report: 2021-04-16

Reporting Person: Ononye-Onyia Sophia Nnenna (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-16	Stock Option (right to buy)	$1.4	A	45000	Acquired	2031-04-16	Common stock (45000.0)	Direct

Footnotes

F1: This option vests as to 1/3rd of the shares subject to this option on each of the first three anniversaries of the transaction date, subject to the reporting person's continued service to the issuer, and will become exercisable in full upon a change of control of the issuer.